This is the authors' abstract. We don't add key points for this paper.
Article1 September 1937A STUDY OF THE DIAGNOSIS AND TREATMENT OF LOBAR PNEUMONIA ACCORDING TO TYPES AND SPECIFIC SERUM THERAPYJULIEN E. BENJAMIN, M.D., F.A.C.P., MARION BLANKENHORN, M.D., JAMES M. RUEGSEGGER, M.D., FANNIE A. SENIORJULIEN E. BENJAMIN, M.D., F.A.C.P.Search for more papers by this author, MARION BLANKENHORN, M.D.Search for more papers by this author, JAMES M. RUEGSEGGER, M.D.Search for more papers by this author, FANNIE A. SENIORSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-11-3-437 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAlthough recent reports of successes in the diagnosis and treatment of the pneumonias, according to specific criteria, have been impressive, it can hardly be said that the medical world is committed to the procedures. There are several valid reasons why this is true. While there have been excellent results reported by reliable observers in the treatment of the acute pneumonias with specific serum, the technical difficulties involved in accurate typing, as well as the expense incurred in the use of curative serum, are the major objections raised, and the ones which have caused clinicians to approach the subject with hesitation....Bibliography1. BENJAMINBLANKENHORNSENIOR JEMFA: The results of the treatment of pneumonia with specific therapeutic serum, Ohio State Med. Jr., 1937, xxxiii, 36. Google Scholar2. SCHIFF L: Pneumonia in the adult, Jr. Med., Cincinnati, 1930, xi, 292-303. Google Scholar3. PARKBULLOWAROSENBLUTH WHJGMB (a) : Treatment of lobar pneumonia with refined specific antibacterial serum, Jr. Am. Med. Assoc., 1928, xci, 1503. (b) CECIL, R. L., and PLUMMER, N.: Pneumococcus Type I pneumonia, Jr. Am. Med. Assoc., 1930, xcv, 1547. (c) COLE, R.: Serum treatment in Type I pneumonia, Jr. Am. Med. Assoc., 1929, xciii, 741. (d) CECIL, R. L., and SUTLIFF, W. D.: Treatment of lobar pneumonia with concentrated antipneumococcus serum, Jr. Am. Med. Assoc., 1928, xci, 2035. (e) WADSWORTH, A. B.: Review of recently published reports on serum treatment of Type I pneumonia, together with report of 445 additional cases, Am. Jr. Hyg., 1924, iv, 119. (f) SUTLIFF, W. D., and FINLAND, M.: Type I pneumococcic infections with especial reference to specific serum treatment, New Eng. Jr. Med., 1934, ccx, 237. (g) FINLAND, M.: The serum treatment of lobar pneumonia, New Eng. Jr. Med., 1930, ccii, 1244. CrossrefGoogle Scholar4. FINLANDDOWLING MHF: Dosage of antibody effective in the treatment of pneumococcus Type II pneumonia, Am. Jr. Med. Sci., 1936, cxci, 658. CrossrefGoogle Scholar5. NICHOLS HJ: Lobar pneumonia problem in the army, N. Y. Med. Jr., 1917, cvi, 219. Google Scholar6. FINLANDTILGHMAN, MRC: Pneumococcic infections in families, Jr. Clin. Invest., 1936, xv, 501. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Cincinnati, Ohio*Read at the St. Louis meeting of the American College of Physicians, April 21, 1937. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDie InfektionskrankheitenDie PneumonienZur Frage der Kreislaufbehandlung bei Lobärer Pneumonie 1 September 1937Volume 11, Issue 3Page: 437-447KeywordsPneumoniaSerotherapy Issue Published: 1 September 1937 PDF downloadLoading ...
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Benjamin et al. (1937) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: